1 / 6

Point of Care (PoC) Diagnostics Market Outlook to 2026: Top Companies, Trends & Growth Factors Details

The latest industry intelligence report on the Point of Care (PoC) Diagnostics Market performs a cautious examination of the current business environment and competitive landscape of the Point of Care (PoC) Diagnostics Market for the forecast period, 2019 - 2026.<br>

shabaz
Download Presentation

Point of Care (PoC) Diagnostics Market Outlook to 2026: Top Companies, Trends & Growth Factors Details

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com

  2. Market Summary According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%. According to the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or pre-diabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union.

  3. Our Approach Market Summary Near patient testing even allows more than just bedside testing. It permits users to improve efficiency and productivity; maybe expensive than traditional diagnostics but more accurate and even reduce staff burden by bringing the focus back on the patient. Key recent developments in the field of Point-of-Care (PoC) diagnostics: In November 2018, PixCell Medical received FDA 510(k) approval for its point of care the HemoScreen Haematology Analyser, which should enable physicians to make more rapid and accurate decisions. High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period. Market Size – USD 23.98 Billion in 2018, Market Growth - CAGR of 9.6%. Market Trends – Product launches and research for Point of Care diagnostic products. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1507

  4. Our Approach Market Summary Key takeaways of the Point of Care (PoC) Diagnostics market report has been enlisted below: A comprehensive overview of the competitive landscape of the Cell Isolation market that examines the market position of leading companies like Abbott,  AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher,  EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, among others that collectively constitute a competitive markethave been studied elaborately in the study. A brief description of all manufacturers, products range, and product applications have been also been provided. The report underlines information pertaining to the leading organizations based on their market positions as well as revenue generated. The report also includes the companies’ reported profit margins and pricing structure.

  5. Our Approach Market Summary Product Type (Revenue, USD Million; 2016–2026) Glucose Monitoring Products Strips Meters Lancets & Lancing Devices End User (Revenue, USD Million; 2016–2026) Professional Diagnostic Centres Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings) Hospitals/Critical Care Centres Home Care Research Laboratories Other End Users Order Now@ https://www.reportsanddata.com/checkout-form/1507

  6. Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Our Approach About Us

More Related